CHOI SOONGYU,CHOI JUNGSUB,YOON SO HYUN,KIM YOO HOON,KIM JAE YEON,LEE SUK HO,CHO YOUNG LAG,SONG HO YOUNG,LEE DAE YON,BAEK SUNG YOON,CHAE SANG EUN,PARK TAE KYO,WOO SUNG HO,KIM YONG ZU
申请号：
IN201717000603
公开号：
IN201717000603A
申请日:
2017.01.06
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The present invention relates to a novel crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]- 1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and a pharmaceutical composition containing the same. The novel crystalline form of a compound according to the present invention exhibits excellent stability even in high-temperature and humidity environments, and thus can be favorably used to prevent or treat diseases, such as thrombosis, myocardial infarction, atherosclerosis, inflammation, stroke, angina pectoris, restenosis after angioplasty, and thromboembolism.
